
Episode #57
How OpenEvidence Became a $12 Billion AI Healthcare Giant | Full Breakdown
<p>OpenEvidence just hit a $12 billion valuation — here's the full story of how it happened. Daniel Nadler sold his first company, Kensho, to S&P Global for $550 million. Then he turned his attention to one of the most broken systems in the world — medical information.</p><p>Hosts Roupen Odabashian, MD and Osama Hyder break down the full story of OpenEvidence — the AI-powered clinical decision support platform now used by 40% of US physicians, handling 358,000 queries per day.</p><p>We cover Daniel's origin story from Toronto to Harvard PhD, the Federal Reserve, and the founding of Kensho in 2013. We explore the $5...






